Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183,579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study.
Oswald LB, Bloomer A, Li X, Jean-Baptiste E, Trujillo G, Felder S, Small BJ, Ose J, Hardikar S, Strehli I, Huang LC, Mooney K, Mutch MG, Chao D, Cohen SA, Karchi M, Wood EH, Damerell V, Loroña NC, Gong J, Toriola AT, Li CI, Shibata D, Schneider M, Gigic B, Figueiredo JC, Jim HSL, Ulrich CM, Siegel EM. Oswald LB, et al. Among authors: li x, li ci. Support Care Cancer. 2024 Apr 19;32(5):298. doi: 10.1007/s00520-024-08511-5. Support Care Cancer. 2024. PMID: 38639810 Free PMC article.
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Tometich DB, Geiss C, Maconi ML, Chavez M, Hoogland AI, Li X, Nieves-Lopez A, Rodriguez Y, Bryant C, Brohl AS, Eroglu Z, Markowitz J, Tarhini AA, Hwu P, Khushalani NI, Jim HSL. Tometich DB, et al. Among authors: li x. Support Care Cancer. 2024 May 6;32(6):330. doi: 10.1007/s00520-024-08538-8. Support Care Cancer. 2024. PMID: 38709312
Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy.
Hoogland AI, Barata A, Li X, Irizarry-Arroyo N, Jain MD, Welniak T, Rodriguez Y, Oswald LB, Gudenkauf LM, Chavez JC, Khimani F, Lazaryan A, Liu HD, Nishihori T, Pinilla-Ibarz J, Shah BD, Crowder SL, Parker NH, Carson TL, Vinci CE, Pidala JA, Logue J, Locke FL, Jim HSL. Hoogland AI, et al. Among authors: li x. Transplant Cell Ther. 2024 Dec;30(12):1219.e1-1219.e11. doi: 10.1016/j.jtct.2024.09.013. Epub 2024 Sep 19. Transplant Cell Ther. 2024. PMID: 39306278
Real-World Patient-Reported and Neurocognitive Outcomes in the Year After Axicabtagene Ciloleucel.
Hoogland AI, Li X, Modi K, Welniak T, Rodriguez Y, Irizarry-Arroyo N, Oswald LB, Snider JT, Wade SW, Chavez J, Corallo S, Booth-Jones M, Jain MD, Locke FL, Jim HSL. Hoogland AI, et al. Among authors: li x. Transplant Cell Ther. 2024 Dec 27:S2666-6367(24)00839-X. doi: 10.1016/j.jtct.2024.12.020. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39733840
183,579 results
You have reached the last available page of results. Please see the User Guide for more information.